Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merus Labs International Inc (NASDAQ:MSLI)

0.8601
Delayed Data
As of Mar 24
 -0.0298 / -3.35%
Today’s Change
0.70
Today|||52-Week Range
1.76
-1.14%
Year-to-Date
No recent news for Merus Labs International Inc.

Today’s Trading

Previous close0.89
Today’s open0.85
Day’s range0.85 - 0.87
Volume900
Average volume (3 months)27,256
Market cap$100.9M
Dividend yield--
Data as of 2:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-3,133.33%
Earnings growth (this year)+46.69%
Earnings growth (next 5 years)+1.14%
Revenue growth (last year)+72.51%
P/E ratio--
Price/Sales1.62
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...0.000.00%
PRQRProQR Therapeutics N...0.000.00%
CPIXCumberland Pharmaceu...+0.01+0.16%
AGLEAeglea Bio Therapeut...+0.05+0.68%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$68.7M
Annual profit (last year)-$7.1M
Net profit margin-10.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Barry Fishman
Chief Financial Officer
Michael Bumby
Corporate headquarters
Toronto, Ontario

Forecasts


Search for Jobs